Article
Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey.
Cancer - 1 Oct 2022
Mesa Ruben A, Sullivan Erin M, Dubinski David, Carroll Brittany, Slee Valerie M, Jennings Susan V, Finnerty Celeste C, Bohannon Linda S, Mathias Susan D, Lahue Betsy J, Castells Mariana C
Abstract excerpt
BACKGROUND: Systemic mastocytosis (SM) is a rare clonal neoplasm driven by the KIT D816V mutation and has a broad range of debilitating symptoms. In this study, the authors evaluated SM disease perceptions and management strategies among US health care providers (HCPs). METHODS: Hematologist/oncologist (H/O) HCPs and allergist/immunologist (A/I) HCPs who were treating four or more patients with SM completed an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.